mRNA capping: Biological functions and applications

Nucleic Acids Research

Volumn 44, Issue 16, 2016, Pages 7511-7526

  Ramanathan, Anand ^a,b   Robb, G Brett ^a   Chan, Siu Hong ^a  

^a NEW ENGLAND BIOLABS   (United States)

^b AGIOS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID HYDROLASE; DNA VACCINE; MESSENGER RNA; RNA GUANYLYLTRANSFERASE; RNA TRIPHOSPHATASE; RNA VACCINE; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS RNA; CAPPED RNA; NUCLEOTIDYLTRANSFERASE;

ALLERGY; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVITY; HUMAN; INFLUENZA; INNATE IMMUNITY; LUNG CANCER; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RNA CAPPING; RNA IMMUNIZATION; RNA PROCESSING; RNA SEQUENCE; RNA TRANSPORT; TRANSLATION INITIATION; ANIMAL; CHEMISTRY; EUKARYOTIC CELL; METABOLISM; MOLECULAR MODEL;

ANIMALS; EUKARYOTIC CELLS; HUMANS; MODELS, MOLECULAR; NUCLEOTIDYLTRANSFERASES; RNA CAPS; RNA, VIRAL;

EID: 84988979122     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw551     Document Type: Review

References (183)

1. Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.-Y., Schneller, S., Zust, R., Dong, H., et al. (2010) 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature, 468, 452-456.
2. Devarkar, S.C., Wang, C., Miller, M.T., Ramanathan, A., Jiang, F., Khan, A.G., Patel, S.S. and Marcotrigiano, J. (2016) Structural basis for m7G recognition and 2′-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I. Proc. Natl. Acad. Sci. U.S.A., 113, 596-601.
3. Mukherjee, C., Bakthavachalu, B. and Schoenberg, D.R. (2014) The cytoplasmic capping complex assembles on adapter protein Nck1 bound to the Proline-rich C-terminus of mammalian capping enzyme. PLoS Biol., 12, e1001933.
4. Ghosh, A. and Lima, C.D. (2010) Enzymology of RNA cap synthesis. Wiley Interdiscip. Rev. RNA, 1, 152-172.
5. Decroly, E., Ferron, F., Lescar, J. and Canard, B. (2012) Conventional and unconventional mechanisms for capping viral mRNA. Nat. Rev. Microbiol., 10, 51-65.
6. Shatkin, A.J. and Manley, J.L. (2000) The ends of the affair: capping and polyadenylation. Nat. Struct. Biol., 7, 838-842.
7. Moteki, S. and Price, D. (2002) Functional coupling of capping and transcription of mRNA. Mol. Cell, 10, 599-609.
8. Martinez-Rucobo, F.W., Kohler, R., van de Waterbeemd, M., Heck, A.J.R., Hemann, M., Herzog, F., Stark, H. and Cramer, P. (2015) Molecular basis of transcription-coupled pre-mRNA capping. Mol. Cell, 58, 1079-1089.
9. Chu, C., Das, K., Tyminski, J.R., Bauman, J.D., Guan, R., Qiu, W., Montelione, G.T., Arnold, E. and Shatkin, A.J. (2011) Structure of the guanylyltransferase domain of human mRNA capping enzyme. Proc. Natl. Acad. Sci. U.S.A., 108, 10104-10108.
10. Yue, Z., Maldonado, E., Pillutla, R., Cho, H., Reinberg, D. and Shatkin, A.J. (1997) Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A., 94, 12898-12903.
11. Saha, N., Schwer, B. and Shuman, S. (1999) Characterization of human, Schizosaccharomyces pombe, and Candida albicans mRNA cap methyltransferases and complete replacement of the yeast capping apparatus by mammalian enzymes. J. Biol. Chem., 274, 16553-16562.
12. Belanger, F., Stepinski, J., Darzynkiewicz, E. and Pelletier, J. (2010) Characterization of hMTr1, a human Cap1 2′-O-ribose methyltransferase. J. Biol. Chem., 285, 33037-33044.
13. Werner, M., Purta, E., Kaminska, K.H., Cymerman, I.A., Campbell, D.A., Mittra, B., Zamudio, J.R., Sturm, N.R., Jaworski, J. and Bujnicki, J.M. (2011) 2′-O-ribose methylation of cap2 in human: function and evolution in a horizontally mobile family. Nucleic Acids Res., 39, 4756-4768.
14. McCracken, S., Fong, N., Rosonina, E., Yankulov, K., Brothers, G., Siderovski, D., Hessel, A., Foster, S., Shuman, S. and Bentley, D.L. (1997) 5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev., 11, 3306-3318.
15. Cho, E.-J., Takagi, T., Moore, C.R. and Buratowski, S. (1997) mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev., 11, 3319-3326.
16. Ghosh, A., Shuman, S. and Lima, C.D. (2011) Structural insights to how mammalian capping enzyme reads the CTD code. Mol. Cell, 43, 299-310.
17. Cowling, V.H. (2010) Regulation of mRNA cap methylation. Biochem. J., 425, 295-302.
18. Gu, M., Rajashankar, K.R. and Lima, C.D. (2010) Structure of the Saccharomyces cerevisiae Cet1-Ceg1 mRNA capping apparatus. Structure, 18, 216-227.
19. Doamekpor, S.K., Sanchez, A.M., Schwer, B., Shuman, S. and Lima, C.D. (2014) How an mRNA capping enzyme reads distinct RNA polymerase II and Spt5 CTD phosphorylation codes. Genes Dev., 28, 1323-1336.
20. van Dijk, E., Cougot, N., Meyer, S., Babajko, S., Wahle, E. and Seraphin, B. (2002) Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J., 21, 6915-6924.
21. Brengues, M. (2005) Movement of Eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science, 310, 486-489.
22. Balagopal, V. and Parker, R. (2009) Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAs. Curr. Opin. Cell Biol., 21, 403-408.
23. Kiss, D.L., Oman, K.M., Dougherty, J.A., Mukherjee, C., Bundschuh, R. and Schoenberg, D.R. (2016) Cap homeostasis is independent of poly(A) tail length. Nucleic Acids Res., 44, 304-314.
24. Schoenberg, D.R. and Maquat, L.E. (2009) Re-capping the message. Trends Biochem. Sci., 34, 435-442.
25. Otsuka, Y., Kedersha, N.L. and Schoenberg, D.R. (2009) Identification of a cytoplasmic complex that adds a cap onto 5′-monophosphate RNA. Mol. Cell. Biol., 29, 2155-2167.
26. Shiraki, T., Kondo, S., Katayama, S., Waki, K., Kasukawa, T., Kawaji, H., Kodzius, R., Watahiki, A., Nakamura, M., Arakawa, T. et al. (2003) Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc. Natl. Acad. Sci. U.S.A., 100, 15776-15781.
27. Kiss, D.L., Oman, K., Bundschuh, R. and Schoenberg, D.R. (2015) Uncapped 5′ ends of mRNAs targeted by cytoplasmic capping map to the vicinity of downstream CAGE tags. FEBS Lett., 589, 279-284.
28. Fejes-Toth, K., Sotirova, V., Sachidanandam, R., Assaf, G., Hannon, G.J., Kapranov, P., Foissac, S., Willingham, A.T., Duttagupta, R., Dumais, E., et al. (2009) Post-transcriptional processing generates a diversity of 5′-modified long and short RNAs. Nature, 457, 1028-1032.
29. Ignatochkina, A. V, Takagi, Y., Liu, Y., Nagata, K. and Ho, C.K. (2015) The messenger RNA decapping and recapping pathway in Trypanosoma. Proc. Natl. Acad. Sci. U.S.A., 112, 6967-6972.
30. Mukherjee, C., Patil, D.P., Kennedy, B.A., Bakthavachalu, B., Bundschuh, R. and Schoenberg, D.R. (2012) Identification of cytoplasmic capping targets reveals a role for cap homeostasis in translation and mRNA stability. Cell Rep., 2, 674-684.
31. Jiao, X., Chang, J.H., Kilic, T., Tong, L. and Kiledjian, M. (2013) A mammalian pre-mRNA 5′ end capping quality control mechanism and an unexpected link of capping to pre-mRNA processing. Mol. Cell, 50, 104-115.
32. Jiao, X., Xiang, S., Oh, C., Martin, C.E., Tong, L. and Kiledjian, M. (2010) Identification of a quality-control mechanism for mRNA 5′-end capping. Nature, 467, 608-611.
33. Xiang, S., Cooper-Morgan, A., Jiao, X., Kiledjian, M., Manley, J.L. and Tong, L. (2009) Structure and function of the 5′->3′ exoribonuclease Rat1 and its activating partner Rai1. Nature, 458, 784-788.
34. Chang, J.H., Jiao, X., Chiba, K., Oh, C., Martin, C.E., Kiledjian, M. and Tong, L. (2012) Dxo1 is a new type of eukaryotic enzyme with both decapping and 5′-3′ exoribonuclease activity. Nat. Struct. Mol. Biol., 19, 1011-1017.
35. Konarska, M.M., Padgett, R.A. and Sharp, P.A. (1984) Recognition of cap structure in splicing in vitro of mRNA precursors. Cell, 38, 731-736.
36. Ohno, M., Sakamoto, H. and Shimura, Y. (1987) Preferential excision of the 5′ proximal intron from mRNA precursors with two introns as mediated by the cap structure. Proc. Natl. Acad. Sci. U.S.A., 84, 5187-5191.
37. Inoue, K., Ohno, M., Sakamoto, H. and Shimura, Y. (1989) Effect of the cap structure on pre-mRNA splicing in Xenopus oocyte nuclei. Genes Dev., 3, 1472-1479.
38. Fresco, L.D. and Buratowski, S. (1996) Conditional mutants of the yeast mRNA capping enzyme show that the cap enhances, but is not required for, mRNA splicing. RNA, 2, 584-596.
39. Topisirovic, I., Svitkin, Y. V, Sonenberg, N. and Shatkin, A.J. (2011) Cap and cap-binding proteins in the control of gene expression. Wiley Interdiscip. Rev. RNA, 2, 277-298.
40. Gonatopoulos-Pournatzis, T. and Cowling, V.H. (2014) Cap-binding complex (CBC). Biochem. J., 457, 231-242.
41. Hocine, S., Singer, R.H. and Grunwald, D. (2010) RNA processing and export. Cold Spring Harb. Perspect. Biol., 2, a000752.
42. Pabis, M., Neufeld, N., Steiner, M.C., Bojic, T., Shav-Tal, Y. and Neugebauer, K.M. (2013) The nuclear cap-binding complex interacts with the U4/U6U5 tri-snRNP and promotes spliceosome assembly in mammalian cells. RNA, 19, 1054-1063.
43. Flaherty, S.M., Fortes, P., Izaurralde, E., Mattaj, I.W. and Gilmartin, G.M. (1997) Participation of the nuclear cap binding complex in pre-mRNA 3′ processing. Proc. Natl. Acad. Sci. U.S.A., 94, 11893-11898.
44. Andersen, P.R., Domanski, M., Kristiansen, M.S., Storvall, H., Ntini, E., Verheggen, C., Schein, A., Bunkenborg, J., Poser, I., Hallais, M., et al. (2013) The human cap-binding complex is functionally connected to the nuclear RNA exosome. Nat. Struct. Mol. Biol., 20, 1367-1376.
45. Izaurralde, E. and Adam, S. (1998) Transport of macromolecules between the nucleus and the cytoplasm. RNA, 4, 351-364.
46. Daneholt, B. (2001) Assembly and transport of a premessenger RNP particle. Proc. Natl. Acad. Sci. U.S.A., 98, 7012-7017.
47. Nojima, T., Hirose, T., Kimura, H. and Hagiwara, M. (2007) The interaction between cap-binding complex and RNA export factor is required for intronless mRNA export. J. Biol. Chem., 282, 15645-15651.
48. Cheng, H., Dufu, K., Lee, C.-S., Hsu, J.L., Dias, A. and Reed, R. (2006) Human mRNA export machinery recruited to the 5′ end of mRNA. Cell, 127, 1389-1400.
49. Carmody, S.R. and Wente, S.R. (2009) mRNA nuclear export at a glance. J. Cell Sci., 122, 1933-1937.
50. Erkmann, J.A. and Kutay, U. (2004) Nuclear export of mRNA: from the site of transcription to the cytoplasm. Exp. Cell Res., 296, 12-20.
51. Fortes, P., Inada, T., Preiss, T., Hentze, M.W., Mattaj, I.W. and Sachs, A.B. (2000) The yeast nuclear cap binding complex can interact with translation factor eIF4G and mediate translation initiation. Mol. Cell, 6, 191-196.
52. Chiu, S.-Y., Lejeune, F., Ranganathan, A.C. and Maquat, L.E. (2004) The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex. Genes Dev., 18, 745-754.
53. Halstead, J.M., Lionnet, T., Wilbertz, J.H., Wippich, F., Ephrussi, A., Singer, R.H. and Chao, J.A. (2015) An RNA biosensor for imaging the first round of translation from single cells to living animals. Science, 347, 1367-1671.
54. Choe, J., Ryu, I., Park, O.H., Park, J., Cho, H., Yoo, J.S., Chi, S.W., Kim, M.K., Song, H.K. and Kim, Y.K. (2014) eIF4AIII enhances translation of nuclear cap-binding complex-bound mRNAs by promoting disruption of secondary structures in 5′UTR. Proc. Natl. Acad. Sci. U.S.A., 111, E4577-E4586.
55. Maquat, L.E., Hwang, J., Sato, H. and Tang, Y. (2010) CBP80-promoted mRNP rearrangements during the pioneer round of translation, nonsense-mediated mRNA decay, and thereafter. Cold Spring Harb. Symp. Quant. Biol., 75, 127-134.
56. Choe, J., Oh, N., Park, S., Lee, Y.K., Song, O.-K., Locker, N., Chi, S.-G. and Kim, Y.K. (2012) Translation initiation on mRNAs bound by nuclear cap-binding protein complex CBP80/20 requires interaction between CBP80/20-dependent translation initiation factor and eukaryotic translation initiation factor 3g. J. Biol. Chem., 287, 18500-18509.
57. Maquat, L.E., Tarn, W.-Y. and Isken, O. (2010) The pioneer round of translation: features and functions. Cell, 142, 368-374.
58. Mahamid, J., Pfeffer, S., Schaffer, M., Villa, E., Danev, R., Kuhn Cuellar, L., Forster, F., Hyman, A.A., Plitzko, J.M. and Baumeister, W. (2016) Visualizing the molecular sociology at the HeLa cell nuclear periphery. Science, 351, 969-972.
59. Preiss, T. and Hentze, M.W. (1998) Dual function of the messenger RNA cap structure in poly(A)-tail-promoted translation in yeast. Nature, 392, 516-520.
60. Preiss, T., Muckenthaler, M. and Hentze, M.W. (1998) Poly(A)-tail-promoted translation in yeast: implications for translational control. RNA, 4, 1321-1331.
61. Preiss, T. and Hentze, M.W. (1999) From factors to mechanisms: translation and translational control in eukaryotes. Curr. Opin. Genet. Dev., 9, 515-521.
62. Smith, R.W.P., Blee, T.K.P. and Gray, N.K. (2014) Poly(A)-binding proteins are required for diverse biological processes in metazoans. Biochem. Soc. Trans., 42, 1229-1237.
63. Muthukrishnan, S., Moss, B., Cooper, J.A. and Maxwell, E.S. (1978) Influence of 5′-terminal cap structure on the initiation of translation of vaccinia virus mRNA. J. Biol. Chem., 253, 1710-1715.
64. Kuge, H. (1998) Cap ribose methylation of c-mos mRNA stimulates translation and oocyte maturation in Xenopus laevis. Nucleic Acids Res., 26, 3208-3214.
65. Loo, Y.-M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M.A., Garcia-Sastre, A., Katze, M.G., et al. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol., 82, 335-345.
66. Peisley, A., Wu, B., Yao, H., Walz, T. and Hur, S. (2013) RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell, 51, 573-583.
67. Binder, M., Eberle, F., Seitz, S., Mucke, N., Huber, C.M., Kiani, N., Kaderali, L., Lohmann, V., Dalpke, A. and Bartenschlager, R. (2011) Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J. Biol. Chem., 286, 27278-27287.
68. Zust, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B.W., Ziebuhr, J., Szretter, K.J., Baker, S.C., Barchet, W., Diamond, M.S., et al. (2011) Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol., 12, 137-143.
69. Bruns, A.M., Leser, G.P., Lamb, R.A. and Horvath, C.M. (2014) The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol. Cell, 55, 771-781.
70. Peisley, A., Jo, M.H., Lin, C., Wu, B., Orme-Johnson, M., Walz, T., Hohng, S. and Hur, S. (2012) Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. Proc. Natl. Acad. Sci. U.S.A., 109, E3340-E3349.
71. Kolakofsky, D., Kowalinski, E. and Cusack, S. (2012) A structure-based model of RIG-I activation. RNA, 18, 2118-2127.
72. Wang, Y., Ludwig, J., Schuberth, C., Goldeck, M., Schlee, M., Li, H., Juranek, S., Sheng, G., Micura, R., Tuschl, T., et al. (2010) Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat. Struct. Mol. Biol., 17, 781-787.
73. Jiang, F., Ramanathan, A., Miller, M.T., Tang, G.-Q., Gale, M., Patel, S.S. and Marcotrigiano, J. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature, 479, 423-427.
74. Ramanathan, A., Devarkar, S.C., Jiang, F., Miller, M.T., Khan, A.G., Marcotrigiano, J. and Patel, S.S. (2016) The autoinhibitory CARD2-Hel2i Interface of RIG-I governs RNA selection. Nucleic Acids Res., 44, 896-909.
75. Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A.J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A.G., Fujimura, T., Rehwinkel, J., et al. (2014) Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature, 514, 372-375.
76. Schuberth-Wagner, C., Ludwig, J., Bruder, A.K., Herzner, A.-M., Zillinger, T., Goldeck, M., Schmidt, T., Schmid-Burgk, J.L., Kerber, R., Wolter, S., et al. (2015) A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2′O-methylated self RNA. Immunity, 43, 41-51.
77. Pichlmair, A., Lassnig, C., Eberle, C.-A., Gorna, M.W., Baumann, C.L., Burkard, T.R., Burckstummer, T., Stefanovic, A., Krieger, S., Bennett, K.L., et al. (2011) IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat. Immunol., 12, 624-630.
78. Abbas, Y.M., Pichlmair, A., Gorna, M.W., Superti-Furga, G. and Nagar, B. (2013) Structural basis for viral 5′-PPP-RNA recognition by human IFIT proteins. Nature, 494, 60-64.
79. Hyde, J.L. and Diamond, M.S. (2015) Innate immune restriction and antagonism of viral RNA lacking 2′-O methylation. Virology, 479-480, 66-74.
80. Diamond, M.S. (2014) IFIT1: A dual sensor and effector molecule that detects non-2′-O methylated viral RNA and inhibits its translation. Cytokine Growth Factor Rev., 25, 543-550.
81. Kumar, P., Sweeney, T.R., Skabkin, M.A., Skabkina, O. V, Hellen, C.U.T. and Pestova, T. V (2014) Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5′-terminal regions of cap0-, cap1- and 5′pppmRNAs. Nucleic Acids Res., 42, 3228-3245.
82. Schlee, M. (2013) Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology, 218, 1322-1335.
83. Changela, A., Ho, C.K., Martins, A., Shuman, S. and Mondragon, A. (2001) Structure and mechanism of the RNA triphosphatase component of mammalian mRNA capping enzyme. EMBO J., 20, 2575-2586.
84. Bisaillon, M. and Shuman, S. (2001) Structure-function analysis of the active site tunnel of yeast RNA triphosphatase. J. Biol. Chem., 276, 17261-17266.
85. Gong, C. and Shuman, S. (2002) Chlorella virus RNA triphosphatase. Mutational analysis and mechanism of inhibition by tripolyphosphate. J. Biol. Chem., 277, 15317-15324.
86. Song, J., Bettendorff, L., Tonelli, M. and Markley, J.L. (2008) Structural basis for the catalytic mechanism of mammalian 25-kDa thiamine triphosphatase. J. Biol. Chem., 283, 10939-10948.
87. Delvaux, D., Kerff, F., Murty, M.R.V.S., Lakaye, B., Czerniecki, J., Kohn, G., Wins, P., Herman, R., Gabelica, V., Heuze, F., et al. (2013) Structural determinants of specificity and catalytic mechanism in mammalian 25-kDa thiamine triphosphatase. Biochim. Biophys. Acta, 1830, 4513-4523.
88. Jain, R. and Shuman, S. (2008) Polyphosphatase activity of CthTTM, a bacterial triphosphate tunnel metalloenzyme. J. Biol. Chem., 283, 31047-31057.
89. Moeder, W., Garcia-Petit, C., Ung, H., Fucile, G., Samuel, M.A., Christendat, D. and Yoshioka, K. (2013) Crystal structure and biochemical analyses reveal that the Arabidopsis triphosphate tunnel metalloenzyme AtTTM3 is a tripolyphosphatase involved in root development. Plant J., 76, 615-626.
90. Delvaux, D., Murty, M.R.V.S., Gabelica, V., Lakaye, B., Lunin, V. V, Skarina, T., Onopriyenko, O., Kohn, G., Wins, P., De Pauw, E., et al. (2011) A specific inorganic triphosphatase from Nitrosomonas europaea: structure and catalytic mechanism. J. Biol. Chem., 286, 34023-34035.
91. Martinez, J., Truffault, V. and Hothorn, M. (2015) Structural determinants for substrate binding and catalysis in triphosphate tunnel metalloenzymes. J. Biol. Chem., 290, 23348-23360.
92. Lima, C.D., Wang, L.K. and Shuman, S. (1999) Structure and mechanism of yeast RNA triphosphatase: an essential component of the mRNA capping apparatus. Cell, 99, 533-543.
93. Shuman, S. and Lima, C.D. (2004) The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases. Curr. Opin. Struct. Biol., 14, 757-764.
94. Shuman, S., Liu, Y. and Schwer, B. (1994) Covalent catalysis in nucleotidyl transfer reactions: essential motifs in Saccharomyces cerevisiae RNA capping enzyme are conserved in Schizosaccharomyces pombe and viral capping enzymes and among polynucleotide ligases. Proc. Natl. Acad. Sci. U.S.A., 91, 12046-12050.
95. Shuman, S. and Hurwitz, J. (1981) Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme-guanylate intermediate. Proc. Natl. Acad. Sci. U.S.A., 78, 187-191.
96. Souliere, M.F., Perreault, J.-P. and Bisaillon, M. (2008) Kinetic and thermodynamic characterization of the RNA guanylyltransferase reaction. Biochemistry, 47, 3863-3874.
97. Theobald, D.L., Mitton-Fry, R.M. and Wuttke, D.S. (2003) Nucleic acid recognition by OB-fold proteins. Annu. Rev. Biophys. Biomol. Struct., 32, 115-133.
98. Arcus, V. (2002) OB-fold domains: a snapshot of the evolution of sequence, structure and function. Curr. Opin. Struct. Biol., 12, 794-801.
99. Flynn, R.L. and Zou, L. (2010) Oligonucleotide/oligosaccharide-binding fold proteins: a growing family of genome guardians. Crit. Rev. Biochem. Mol. Biol., 45, 266-275.
100. Hakansson, K., Doherty, A.J., Shuman, S. and Wigley, D.B. (1997) X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes. Cell, 89, 545-553.
101. Schubert, H.L., Blumenthal, R.M. and Cheng, X. (2003) Many paths to methyltransfer: a chronicle of convergence. Trends Biochem. Sci., 28, 329-335.
102. Byszewska, M., Smietanski, M., Purta, E. and Bujnicki, J.M. (2014) RNA methyltransferases involved in 5′ cap biosynthesis. RNA Biol., 11, 1597-1607.
103. Bheemanaik, S., Reddy, Y.V.R. and Rao, D.N. (2006) Structure, function and mechanism of exocyclic DNA methyltransferases. Biochem. J., 399, 177-190.
104. Fabrega, C., Hausmann, S., Shen, V., Shuman, S. and Lima, C.D. (2004) Structure and mechanism of mRNA cap (guanine-N7) methyltransferase. Mol. Cell, 13, 77-89.
105. Sutton, G., Grimes, J.M., Stuart, D.I. and Roy, P. (2007) Bluetongue virus VP4 is an RNA-capping assembly line. Nat. Struct. Mol. Biol., 14, 449-451.
106. Fernandez-Sanchez, M.E., Gonatopoulos-Pournatzis, T., Preston, G., Lawlor, M.A. and Cowling, V.H. (2009) S-adenosyl homocysteine hydrolase is required for Myc-induced mRNA cap methylation, protein synthesis, and cell proliferation. Mol. Cell. Biol., 29, 6182-6191.
107. Cole, M.D. and Cowling, V.H. (2009) Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors. Oncogene, 28, 1169-1175.
108. Gonatopoulos-Pournatzis, T., Dunn, S., Bounds, R. and Cowling, V.H. (2011) RAM/Fam103a1 is required for mRNA cap methylation. Mol. Cell, 44, 585-596.
109. Aregger, M. and Cowling, V.H. (2013) Human cap methyltransferase (RNMT) N-terminal non-catalytic domain mediates recruitment to transcription initiation sites. Biochem. J., 455, 67-73.
110. Aregger, M., Kaskar, A., Varshney, D., Fernandez-Sanchez, M.E., Inesta-Vaquera, F.A., Weidlich, S. and Cowling, V.H. (2016) CDK1-Cyclin B1 activates RNMT, coordinating mRNA cap methylation with G1 phase transcription. Mol. Cell, 61, 734-746.
111. Ahola, T. and Kaariainen, L. (1995) Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc. Natl. Acad. Sci. U.S.A., 92, 507-511.
112. Vasiljeva, L., Merits, A., Auvinen, P. and Kaariainen, L. (2000) Identification of a novel function of the alphavirus capping apparatus. RNA 5′-triphosphatase activity of Nsp2. J. Biol. Chem., 275, 17281-17287.
113. Shirako, Y., Strauss, E.G. and Strauss, J.H. (2000) Suppressor mutations that allow sindbis virus RNA polymerase to function with nonaromatic amino acids at the N-terminus: evidence for interaction between nsP1 and nsP4 in minus-strand RNA synthesis. Virology, 276, 148-160.
114. Fata, C.L., Sawicki, S.G. and Sawicki, D.L. (2002) Modification of Asn374 of nsP1 suppresses a Sindbis virus nsP4 minus-strand polymerase mutant. J. Virol., 76, 8641-8649.
115. Li, J., Wang, J.T. and Whelan, S.P.J. (2006) A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc. Natl. Acad. Sci. U.S.A., 103, 8493-8498.
116. Ogino, T. and Banerjee, A.K. (2007) Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol. Cell, 25, 85-97.
117. Ogino, T., Yadav, S.P. and Banerjee, A.K. (2010) Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc. Natl. Acad. Sci. U.S.A., 107, 3463-3468.
118. Ogino, T. (2013) In vitro capping and transcription of rhabdoviruses. Methods, 59, 188-198.
119. Dong, H., Ray, D., Ren, S., Zhang, B., Puig-Basagoiti, F., Takagi, Y., Ho, C.K., Li, H. and Shi, P.Y. (2007) Distinct RNA elements confer specificity to flavivirus RNA cap methylation events. J. Virol., 81, 4412-4421.
120. Dong, H., Ren, S., Zhang, B., Zhou, Y., Puig-Basagoiti, F., Li, H. and Shi, P.-Y. (2008) West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism. J. Virol., 82, 4295-4307.
121. Higman, M.A., Christen, L.A. and Niles, E.G. (1994) The mRNA (guanine-7-)methyltransferase domain of the vaccinia virus mRNA capping enzyme. Expression in Escherichia coli and structural and kinetic comparison to the intact capping enzyme. J. Biol. Chem., 269, 14974-14981.
122. Mao, X. and Shuman, S. (1994) Intrinsic RNA (guanine-7) methyltransferase activity of the vaccinia virus capping enzyme D1 subunit is stimulated by the D12 subunit. Identification of amino acid residues in the D1 protein required for subunit association and methyl group transfer. J. Biol. Chem., 269, 24472-24479.
123. Schwer, B. and Shuman, S. (2006) Genetic analysis of poxvirus mRNA cap methyltransferase: Suppression of conditional mutations in the stimulatory D12 subunit by second-site mutations in the catalytic D1 subunit. Virology, 352, 145-156.
124. De La Pea, M., Kyrieleis, O.J.P. and Cusack, S. (2007) Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase. EMBO J., 26, 4913-4925.
125. Kyrieleis, O.J., Chang, J., de la Pena, M., Shuman, S. and Cusack, S. (2014) Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus. Structure, 22, 452-465.
126. Le Blois, H., French, T., Mertens, P.P., Burroughs, J.N. and Roy, P. (1992) The expressed VP4 protein of bluetongue virus binds GTP and is the candidate guanylyl transferase of the virus. Virology, 189, 757-761.
127. Martinez-Costas, J., Sutton, G., Ramadevi, N. and Roy, P. (1998) Guanylyltransferase and RNA 5′-triphosphatase activities of the purified expressed VP4 protein of bluetongue virus. J. Mol. Biol., 280, 859-866.
128. Ramadevi, N., Burroughs, N.J., Mertens, P.P., Jones, I.M. and Roy, P. (1998) Capping and methylation of mRNA by purified recombinant VP4 protein of bluetongue virus. Proc. Natl. Acad. Sci. U.S.A., 95, 13537-13542.
129. Ramadevi, N., Rodriguez, J. and Roy, P. (1998) A leucine zipper-like domain is essential for dimerization and encapsidation of bluetongue virus nucleocapsid protein VP4. J. Virol., 72, 2983-2990.
130. Sugiyama, K., Obayashi, E., Kawaguchi, A., Suzuki, Y., Tame, J.R.H., Nagata, K. and Park, S.-Y. (2009) Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase. EMBO J., 28, 1803-1811.
131. Reich, S., Guilligay, D., Pflug, A., Malet, H., Berger, I., Crepin, T., Hart, D., Lunardi, T., Nanao, M., Ruigrok, R.W.H., et al. (2014) Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature, 516, 361-366.
132. Huet, S., Avilov, S. V, Ferbitz, L., Daigle, N., Cusack, S. and Ellenberg, J. (2010) Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy. J. Virol., 84, 1254-1264.
133. Dias, A., Bouvier, D., Crepin, T., McCarthy, A.A., Hart, D.J., Baudin, F., Cusack, S. and Ruigrok, R.W. (2009) The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature, 458, 914-918.
134. Plotch, S.J., Bouloy, M. and Krug, R.M. (1979) Transfer of 5′-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc. Natl. Acad. Sci. U.S.A., 76, 1618-1622.
135. Plotch, S.J., Bouloy, M., Ulmanen, I. and Krug, R.M. (1981) A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell, 23, 847-858.
136. Ruigrok, R.W., Crepin, T., Hart, D.J. and Cusack, S. (2010) Towards an atomic resolution understanding of the influenza virus replication machinery. Curr. Opin. Struct. Biol., 20, 104-113.
137. Krug, R.M., Broni, B.A. and Bouloy, M. (1979) Are the 5′ ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell, 18, 329-334.
138. Gu, W., Gallagher, G.R., Dai, W., Liu, P., Li, R., Trombly, M.I., Gammon, D.B., Mello, C.C., Wang, J.P. and Finberg, R.W. (2015) Influenza A virus preferentially snatches noncoding RNA caps. RNA, 21, 2067-2075.
139. Fujimura, T. and Esteban, R. (2012) Cap snatching of yeast L-A double-stranded RNA virus can operate in trans and requires viral polymerase actively engaging in transcription. J. Biol. Chem., 287, 12797-12804.
140. Fujimura, T. and Esteban, R. (2011) Cap-snatching mechanism in yeast L-A double-stranded RNA virus. Proc. Natl. Acad. Sci. U.S.A., 108, 17667-17671.
141. Fujimura, T. and Esteban, R. (2013) Cap snatching in yeast L-BC double-stranded RNA totivirus. J. Biol. Chem., 288, 23716-23724.
142. Blanc, A., Goyer, C. and Sonenberg, N. (1992) The coat protein of the yeast double-stranded RNA virus L-A attaches covalently to the cap structure of eukaryotic mRNA. Mol. Cell. Biol., 12, 3390-3398.
143. Blanc, A., Ribas, J.C., Wickner, R.B. and Sonenberg, N. (1994) His-154 is involved in the linkage of the Saccharomyces cerevisiae L-A double-stranded RNA virus Gag protein to the cap structure of mRNAs and is essential for M1 satellite virus expression. Mol. Cell. Biol., 14, 2664-2674.
144. Gunawardana, D., Domashevskiy, A. V, Gayler, K.R. and Goss, D.J. (2015) Efficient preparation and properties of mRNAs containing a fluorescent cap analog: Anthraniloyl-m(7)GpppG. Transl. (Austin, Tex.), 3, e988538.
145. Ettwiller, L., Buswell, J., Yigit, E. and Schildkraut, I. (2016) A novel enrichment strategy reveals unprecedented number of novel transcription start sites at single base resolution in a model prokaryote and the gut microbiome. BMC Genomics, 17, 199.
146. Quabius, E.S. and Krupp, G. (2015) Synthetic mRNAs for manipulating cellular phenotypes: an overview. N. Biotechnol., 32, 229-235.
147. Hansson, M.L., Albert, S., Gonzalez Somermeyer, L., Peco, R., Mejia-Ramirez, E., Montserrat, N. and Izpisua Belmonte, J.C. (2015) Efficient delivery and functional expression of transfected modified mRNA in human embryonic stem cell-derived retinal pigmented epithelial cells. J. Biol. Chem., 290, 5661-5672.
148. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A., et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630.
149. Avci-Adali, M., Behring, A., Keller, T., Krajewski, S., Schlensak, C. and Wendel, H.P. (2014) Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression. J. Biol. Eng., 8, 8.
150. Deering, R.P., Kommareddy, S., Ulmer, J.B., Brito, L.A. and Geall, A.J. (2014) Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opin. Drug Deliv., 11, 885-899.
151. Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B.L., Tam, Y.K., Madden, T.D., Hope, M.J. and Weissman, D. (2015) Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control. Release, 217, 345-351.
152. Weiner, D.B. (2013) RNA-based vaccination: sending a strong message. Mol. Ther., 21, 506-508.
153. Brito, L.A., Chan, M., Shaw, C.A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G.R., Beard, C.W., et al. (2014) A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Mol. Ther., 22, 2118-2129.
154. Van Lint, S., Heirman, C., Thielemans, K. and Breckpot, K. (2013) mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic. Hum. Vaccin. Immunother., 9, 265-274.
155. Probst, J., Weide, B., Scheel, B., Pichler, B.J., Hoerr, I., Rammensee, H.-G. and Pascolo, S. (2007) Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther., 14, 1175-1180.
156. Phua, K.K.L., Staats, H.F., Leong, K.W. and Nair, S.K. (2014) Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity. Sci. Rep., 4, 5128.
157. Tavernier, G., Andries, O., Demeester, J., Sanders, N.N., De Smedt, S.C. and Rejman, J. (2011) mRNA as gene therapeutic: how to control protein expression. J. Control. Release, 150, 238-247.
158. Hecker, J.G., Hall, L.L. and Irion, V.R. (2001) Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. Mol. Ther., 3, 375-384.
159. Anderson, D.M., Hall, L.L., Ayyalapu, A.R., Irion, V.R., Nantz, M.H. and Hecker, J.G. (2003) Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. Hum. Gene Ther., 14, 191-202.
160. Kormann, M.S.D., Hasenpusch, G., Aneja, M.K., Nica, G., Flemmer, A.W., Herber-Jonat, S., Huppmann, M., Mays, L.E., Illenyi, M., Schams, A., et al. (2011) Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat. Biotechnol., 29, 154-157.
161. Kariko, K., Muramatsu, H., Keller, J.M. and Weissman, D. (2012) Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol. Ther., 20, 948-953.
162. Kariko, K., Buckstein, M., Ni, H. and Weissman, D. (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity, 23, 165-175.
163. Anderson, B.R., Muramatsu, H., Nallagatla, S.R., Bevilacqua, P.C., Sansing, L.H., Weissman, D. and Kariko, K. (2010) Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res., 38, 5884-5892.
164. Geall, A.J. and Ulmer, J.B. (2015) Introduction to RNA-based vaccines and therapeutics. Expert Rev. Vaccines, 14, 151-152.
165. Petsch, B., Schnee, M., Vogel, A.B., Lange, E., Hoffmann, B., Voss, D., Schlake, T., Thess, A., Kallen, K.-J., Stitz, L., et al. (2012) Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat. Biotechnol., 30, 1210-1216.
166. Hekele, A., Bertholet, S., Archer, J., Gibson, D.G., Palladino, G., Brito, L.A., Otten, G.R., Brazzoli, M., Buccato, S., Bonci, A., et al. (2013) Rapidly produced SAMR® vaccine against H7N9 influenza is immunogenic in mice. Emerg. Microbes Infect., 2, e52.
167. Weiss, R., Scheiblhofer, S., Roesler, E., Ferreira, F. and Thalhamer, J. (2010) Prophylactic mRNA vaccination against allergy. Curr. Opin. Allergy Clin. Immunol., 10, 567-574.
168. Roesler, E., Weiss, R., Weinberger, E.E., Fruehwirth, A., Stoecklinger, A., Mostbock, S., Ferreira, F., Thalhamer, J. and Scheiblhofer, S. (2009) Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens. J. Allergy Clin. Immunol., 124, e1-e11.
169. Fotin-Mleczek, M., Zanzinger, K., Heidenreich, R., Lorenz, C., Kowalczyk, A., Kallen, K.-J. and Huber, S.M. (2014) mRNA-based vaccines synergize with radiation therapy to eradicate established tumors. Radiat. Oncol., 9, 180.
170. Fotin-Mleczek, M., Zanzinger, K., Heidenreich, R., Lorenz, C., Thess, A., Duchardt, K.M. and Kallen, K.-J. (2012) Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect. J. Gene Med., 14, 428-439.
171. Kubler, H., Scheel, B., Gnad-Vogt, U., Miller, K., Schultze-Seemann, W., Vom Dorp, F., Parmiani, G., Hampel, C., Wedel, S., Trojan, L., et al. (2015) Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study. J. Immunother. cancer, 3, 26.
172. Johanning, F.W., Conry, R.M., LoBuglio, A.F., Wright, M., Sumerel, L.A., Pike, M.J. and Curiel, D.T. (1995) A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo. Nucleic Acids Res., 23, 1495-1501.
173. Geall, A.J., Verma, A., Otten, G.R., Shaw, C.A., Hekele, A., Banerjee, K., Cu, Y., Beard, C.W., Brito, L.A., Krucker, T., et al. (2012) Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl. Acad. Sci. U.S.A., 109, 14604-14609.
174. Brito, L.A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Berlanda Scorza, F., Otten, G.R., Yu, D., Mandl, C.W., Mason, P.W. et al. (2015) Self-amplifying mRNA vaccines. Adv. Genet., 89, 179-233.
175. Adiconis, X., Borges-Rivera, D., Satija, R., DeLuca, D.S., Busby, M.A., Berlin, A.M., Sivachenko, A., Thompson, D.A., Wysoker, A., Fennell, T., et al. (2013) Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat. Methods, 10, 623-629.
176. Qiu, Z.R., Shuman, S. and Schwer, B. (2011) An essential role for trimethylguanosine RNA caps in Saccharomyces cerevisiae meiosis and their requirement for splicing of SAE3 and PCH2 meiotic pre-mRNAs. Nucleic Acids Res., 39, 5633-5646.
177. Chang, J., Schwer, B. and Shuman, S. (2010) Mutational analyses of trimethylguanosine synthase (Tgs1) and Mud2: proteins implicated in pre-mRNA splicing. RNA, 16, 1018-1031.
178. Cosgrove, M.S., Ding, Y., Rennie, W.A., Lane, M.J. and Hanes, S.D. (2012) The Bin3 RNA methyltransferase targets 7SK RNA to control transcription and translation. Wiley Interdiscip. Rev. RNA, 3, 633-647.
179. Xhemalce, B., Robson, S.C. and Kouzarides, T. (2012) Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell, 151, 278-288.
180. Abdelhamid, R.F., Plessy, C., Yamauchi, Y., Taoka, M., de Hoon, M., Gingeras, T.R., Isobe, T. and Carninci, P. (2014) Multiplicity of 5′ cap structures present on short RNAs. PLoS One, 9, e102895.
181. Chen, Y.G., Kowtoniuk, W.E., Agarwal, I., Shen, Y. and Liu, D.R. (2009) LC/MS analysis of cellular RNA reveals NAD-linked RNA. Nat. Chem. Biol., 5, 879-881.
182. Kowtoniuk, W.E., Shen, Y., Heemstra, J.M., Agarwal, I. and Liu, D.R. (2009) A chemical screen for biological small molecule-RNA conjugates reveals CoA-linked RNA. Proc. Natl. Acad. Sci. U.S.A., 106, 7768-7773.
183. Cahova, H., Winz, M.-L., Hofer, K., Nubel, G. and Jaschke, A. (2015) NAD captureSeq indicates NAD as a bacterial cap for a subset of regulatory RNAs. Nature, 519, 374-377.